FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309470132> ?p ?o ?g. }

• W4309470132 endingPage "18" @default.
• W4309470132 startingPage "10" @default.
• W4309470132 abstract "Patients with glioblastoma have a high risk of developing venous thromboembolism (VTE). However, the role of underlying genetic risk factors remains largely unknown. Therefore, the aim of this study was to discover whether genetic aberrations in glioblastoma associate with VTE risk.In this cohort study, all consecutive patients diagnosed with glioblastoma in two Dutch hospitals between February 2017 and August 2020 were included. Targeted DNA next-generation sequencing of all glioblastomas was performed for diagnostic purposes and included mutational status of the genes ATRX, BRAF, CIC, FUBP1, H3F3A, IDH1, IDH2, PIK3CA, PTEN and TP53 and amplification/gain or deletion of BRAF, CDKN2A, EGFR, NOTCH1 and PTEN. The primary outcome was VTE within three months before glioblastoma diagnosis until two years after. Cumulative incidences were determined using competing risk analysis adjusting for mortality. Univariable Cox regression analysis was performed to determine hazard ratios.From 324 patients with glioblastoma, 25 were diagnosed with VTE. Patients with a CDKN2A deletion had a 12-month adjusted cumulative incidence of VTE of 12.5 % (95%CI: 7.3-19.3) compared with 5.4 % (95%CI: 2.6-9.6) in patients with CDKN2A wildtype (p = 0.020), corresponding to a HR of 2.53 (95%CI: 1.12-5.73, p = 0.026). No significant associations were found between any of the other investigated genes and VTE.This study suggests a potential role for CDKN2A deletion in glioblastoma-related VTE. Therefore, once independently validated, CDKN2A mutational status may be a promising predictor to identify glioblastoma patients at high risk for VTE, who may benefit from thromboprophylaxis." @default.
• W4309470132 created "2022-11-28" @default.
• W4309470132 creator A5004901028 @default.
• W4309470132 creator A5008013552 @default.
• W4309470132 creator A5016495519 @default.
• W4309470132 creator A5027431274 @default.
• W4309470132 creator A5034331526 @default.
• W4309470132 creator A5037073179 @default.
• W4309470132 creator A5040307853 @default.
• W4309470132 creator A5044180782 @default.
• W4309470132 creator A5056837393 @default.
• W4309470132 creator A5061736905 @default.
• W4309470132 creator A5064012002 @default.
• W4309470132 creator A5086386408 @default.
• W4309470132 creator A5089043480 @default.
• W4309470132 creator A5090278878 @default.
• W4309470132 creator A5091666538 @default.
• W4309470132 date "2023-01-01" @default.
• W4309470132 modified "2023-09-27" @default.
• W4309470132 title "Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study" @default.
• W4309470132 cites W1497063493 @default.
• W4309470132 cites W1497153827 @default.
• W4309470132 cites W1967466510 @default.
• W4309470132 cites W1969576610 @default.
• W4309470132 cites W1969603890 @default.
• W4309470132 cites W1976182266 @default.
• W4309470132 cites W1987751327 @default.
• W4309470132 cites W1996600303 @default.
• W4309470132 cites W1999330214 @default.
• W4309470132 cites W1999429023 @default.
• W4309470132 cites W2003714769 @default.
• W4309470132 cites W2023583487 @default.
• W4309470132 cites W2025183726 @default.
• W4309470132 cites W2040790582 @default.
• W4309470132 cites W2042794988 @default.
• W4309470132 cites W2065891752 @default.
• W4309470132 cites W2084891010 @default.
• W4309470132 cites W2096738469 @default.
• W4309470132 cites W2097403264 @default.
• W4309470132 cites W2110016800 @default.
• W4309470132 cites W2114843025 @default.
• W4309470132 cites W2122051587 @default.
• W4309470132 cites W2130081837 @default.
• W4309470132 cites W2130511906 @default.
• W4309470132 cites W2149441684 @default.
• W4309470132 cites W2150638747 @default.
• W4309470132 cites W2156617860 @default.
• W4309470132 cites W2164482341 @default.
• W4309470132 cites W2168454329 @default.
• W4309470132 cites W2346066981 @default.
• W4309470132 cites W2464339606 @default.
• W4309470132 cites W252999267 @default.
• W4309470132 cites W2569189109 @default.
• W4309470132 cites W2619705272 @default.
• W4309470132 cites W2734243012 @default.
• W4309470132 cites W2900953219 @default.
• W4309470132 cites W2922553506 @default.
• W4309470132 cites W2943435350 @default.
• W4309470132 cites W2989714602 @default.
• W4309470132 cites W3003383849 @default.
• W4309470132 cites W3100796456 @default.
• W4309470132 cites W3108038580 @default.
• W4309470132 cites W3138501536 @default.
• W4309470132 cites W3174246647 @default.
• W4309470132 cites W4211103741 @default.
• W4309470132 cites W4224320530 @default.
• W4309470132 cites W4247691581 @default.
• W4309470132 cites W4292229870 @default.
• W4309470132 doi "https://doi.org/10.1016/j.thromres.2022.11.013" @default.
• W4309470132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36435047" @default.
• W4309470132 hasPublicationYear "2023" @default.
• W4309470132 type Work @default.
• W4309470132 citedByCount "0" @default.
• W4309470132 crossrefType "journal-article" @default.
• W4309470132 hasAuthorship W4309470132A5004901028 @default.
• W4309470132 hasAuthorship W4309470132A5008013552 @default.
• W4309470132 hasAuthorship W4309470132A5016495519 @default.
• W4309470132 hasAuthorship W4309470132A5027431274 @default.
• W4309470132 hasAuthorship W4309470132A5034331526 @default.
• W4309470132 hasAuthorship W4309470132A5037073179 @default.
• W4309470132 hasAuthorship W4309470132A5040307853 @default.
• W4309470132 hasAuthorship W4309470132A5044180782 @default.
• W4309470132 hasAuthorship W4309470132A5056837393 @default.
• W4309470132 hasAuthorship W4309470132A5061736905 @default.
• W4309470132 hasAuthorship W4309470132A5064012002 @default.
• W4309470132 hasAuthorship W4309470132A5086386408 @default.
• W4309470132 hasAuthorship W4309470132A5089043480 @default.
• W4309470132 hasAuthorship W4309470132A5090278878 @default.
• W4309470132 hasAuthorship W4309470132A5091666538 @default.
• W4309470132 hasBestOaLocation W43094701321 @default.
• W4309470132 hasConcept C104317684 @default.
• W4309470132 hasConcept C121608353 @default.
• W4309470132 hasConcept C126322002 @default.
• W4309470132 hasConcept C127848430 @default.
• W4309470132 hasConcept C143998085 @default.
• W4309470132 hasConcept C190283241 @default.
• W4309470132 hasConcept C207103383 @default.
• W4309470132 hasConcept C2776194525 @default.

• next